SEC Filing Details

Detailed Financial Reporting & Filings

Access Aprea Therapeutics’ quarterly and annual reports, earnings disclosures, and SEC filings. These financial documents reflect our commitment to transparency, regulatory compliance, and delivering clear insight into our operational and fiscal performance.

Document Details

Form
Filing Date
Jun 17, 2026
Document Date
Jun 16, 2026
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Aprea Therapeutics
Issuer
Aprea Therapeutics, Inc.
Filer
BIZZARI JEAN-PIERRE